Life Pharmacy Group Booking System
* Fields marked with an asterisk must be completed
Time left to complete this booking: 15:00

About Your Vaccination

During your appointment, the following will occur:

- The facilitator will ask questions to ensure you are safe to have the service
- The facilitator will answer any questions you have about the service

Please note, there is a mandatory requirement for anyone who has received a vaccine to stay in the proximity of the vaccination service for 15 minutes after receiving the vaccination, so our pharamcists can effectively manage any adverse events following immunisation.

Post vaccination wait time: 15 mins

Introduction to the Varicella Vaccination:

The Varicella vaccination, sanctioned by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a vital defense against Varicella (chickenpox), this vaccine is a pivotal component of preventive healthcare, contributing to the protection of individuals and communities.

Formulated with proven technology, the Varicella vaccine is recommended for individuals seeking comprehensive protection against this viral infection. Current guidelines underscore the significance of the Varicella vaccination, aligning with the latest public health recommendations.

Who Should Consider the Varicella Vaccination:

The Varicella vaccine is specifically recommended for individuals in need of robust protection against Varicella (chickenpox). ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing Varicella infections. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Varicella vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the potential consequences of Varicella infections. Your local pharmacy is ready to guide and support you throughout the Varicella vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Haemophilus Influenzae Vaccination:

The Haemophilus Influenzae vaccination, endorsed by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a crucial defense against Haemophilus Influenzae bacterial infections, this vaccine is a pivotal component of preventive healthcare, contributing to the protection of individuals and communities.

Formulated with proven technology, the Haemophilus Influenzae vaccine is recommended for individuals seeking comprehensive protection against this bacterial infection. Current guidelines underscore the significance of the Haemophilus Influenzae vaccination, aligning with the latest public health recommendations.

Who Should Consider the Haemophilus Influenzae Vaccination:

The Haemophilus Influenzae vaccine is specifically recommended for individuals in need of robust protection against Haemophilus Influenzae infections. ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing these bacterial infections. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Haemophilus Influenzae vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the potential consequences of Haemophilus Influenzae infections. Your local pharmacy is ready to guide and support you throughout the Haemophilus Influenzae vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Hepatitis A Vaccination:

The Hepatitis A vaccination, approved by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a vital shield against Hepatitis A, this vaccine plays a pivotal role in preventive healthcare efforts, contributing to the protection of individuals and communities.

Formulated with proven technology, the Hepatitis A vaccine is recommended for individuals seeking comprehensive protection against this viral infection. Current guidelines underscore the importance of the Hepatitis A vaccine, aligning with the latest public health recommendations.

Who Should Consider the Hepatitis A Vaccination:

The Hepatitis A vaccine is specifically recommended for individuals in need of robust protection against Hepatitis A. ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing Hepatitis A infection. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Hepatitis A vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the spread of Hepatitis A, a contagious viral infection. Your local pharmacy is ready to guide and support you throughout the Hepatitis A vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Hepatitis B Vaccination:

The Hepatitis B vaccination, authorised by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a crucial defense against Hepatitis B, this vaccine plays a pivotal role in preventive healthcare efforts, contributing to the protection of individuals and communities.

Crafted with proven technology, the Hepatitis B vaccine is recommended for individuals seeking comprehensive protection against this viral infection. Current guidelines underscore the importance of the Hepatitis B vaccine, aligning with the latest public health recommendations.

Who Should Consider the Hepatitis B Vaccination:

The Hepatitis B vaccine is specifically recommended for individuals in need of robust protection against Hepatitis B. ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing Hepatitis B infection. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Hepatitis B vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the spread of Hepatitis B, a potentially serious viral infection. Your local pharmacy is ready to guide and support you throughout the Hepatitis B vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Gardasil-9 Vaccination:

The Gardasil-9 vaccination, endorsed by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a critical defense against certain strains of Human Papillomavirus (HPV), this vaccine is a vital component of preventive healthcare, contributing to the protection of individuals and communities.

Formulated with proven technology, the Gardasil-9 vaccine is recommended for individuals seeking comprehensive protection against several strains of HPV. Current guidelines underscore the significance of the Gardasil-9 vaccination, aligning with the latest public health recommendations.

Who Should Consider the Gardasil-9 Vaccination:

The Gardasil-9 vaccine is specifically recommended for individuals in need of robust protection against specific strains of HPV. ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing HPV-related infections. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Gardasil-9 vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the potential consequences of HPV-related infections. Your local pharmacy is ready to guide and support you throughout the Gardasil-9 vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

In Australia, influenza stands as the most prevalent vaccine-preventable disease, its impact ranging from mild symptoms to severe illness and even death among otherwise healthy individuals. Hospitalization can become necessary in cases of severe influenza, underscoring the importance of vaccination.

Annual influenza vaccination is strongly recommended for individuals aged six months and above. Specific emphasis is placed on certain demographics, including children aged between six months and under five years, adults aged 65 years and above, Aboriginal and Torres Strait Islander populations, and those with medical conditions predisposing them to severe influenza. Additionally, pregnant women, healthcare workers, carers, and individuals in close contact with high-risk groups are urged to get vaccinated.

Further recommendations extend to residents, staff, volunteers, and visitors of aged care and long-term residential facilities, as well as workers in the commercial poultry and pork industry and those providing essential community services. Travelers during influenza season are also advised to receive vaccination.

It is emphasized that annual vaccination is essential due to the changing nature of influenza viruses. While most individuals require only one dose per year, certain groups, such as children between six months and under nine years receiving the vaccine for the first time, or those undergoing specific medical treatments, necessitate two doses administered four weeks apart.

Individuals aged 65 and over are entitled to a free vaccine. This initiative aims to ensure broader access to vaccination among the most vulnerable population.

Introduction to the Measles, Mumps, Rubella (MMR) Vaccination:

The Measles, Mumps, Rubella (MMR) vaccination, endorsed by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a crucial preventive measure, this vaccine has been specifically designed to protect against measles, mumps, and rubella, contributing to ongoing efforts to ensure public health.

Crafted for broad application, the MMR vaccine employs well-established technology for immunisation. It is recommended for individuals seeking comprehensive protection against measles, mumps, and rubella. Current guidelines emphasise the importance of the MMR vaccine, aligning with the latest public health recommendations.

Who Should Consider the MMR Vaccination:

The MMR vaccine is specifically recommended for individuals, especially children, in need of robust protection against measles, mumps, and rubella. ATAGI endorses its use for this purpose, and the vaccine has a proven track record of effectively preventing these contagious diseases. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the MMR vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunisation safeguards against the spread of these highly contagious diseases. Your local pharmacy is ready to guide and support you throughout the MMR vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Meningococcal ACWY Vaccination:

The Meningococcal ACWY vaccination, sanctioned by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a critical defense against Meningococcal ACWY bacterial infections, this vaccine is a pivotal component of preventive healthcare, contributing to the protection of individuals and communities.

Formulated with proven technology, the Meningococcal ACWY vaccine is recommended for individuals seeking comprehensive protection against these bacterial infections. Current guidelines underscore the significance of the Meningococcal ACWY vaccination, aligning with the latest public health recommendations.

Who Should Consider the Meningococcal ACWY Vaccination:

The Meningococcal ACWY vaccine is specifically recommended for individuals in need of robust protection against Meningococcal ACWY infections. ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing these bacterial infections. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Meningococcal ACWY vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the potential consequences of Meningococcal ACWY infections. Your local pharmacy is ready to guide and support you throughout the Meningococcal ACWY vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Meningococcal B Vaccination:

The Meningococcal B vaccination, authorised by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a critical defense against Meningococcal B bacterial infections, this vaccine is a pivotal component of preventive healthcare, contributing to the protection of individuals and communities.

Formulated with proven technology, the Meningococcal B vaccine is recommended for individuals seeking comprehensive protection against this specific bacterial infection. Current guidelines underscore the significance of the Meningococcal B vaccination, aligning with the latest public health recommendations.

Who Should Consider the Meningococcal B Vaccination:

The Meningococcal B vaccine is specifically recommended for individuals in need of robust protection against Meningococcal B infections. ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing these bacterial infections. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Meningococcal B vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the potential consequences of Meningococcal B infections. Your local pharmacy is ready to guide and support you throughout the Meningococcal B vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Meningococcal C Vaccination:

The Meningococcal C vaccination, authorised by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a critical defense against Meningococcal C bacterial infections, this vaccine is a pivotal component of preventive healthcare, contributing to the protection of individuals and communities.

Formulated with proven technology, the Meningococcal C vaccine is recommended for individuals seeking comprehensive protection against this specific bacterial infection. Current guidelines underscore the significance of the Meningococcal C vaccination, aligning with the latest public health recommendations.

Who Should Consider the Meningococcal C Vaccination:

The Meningococcal C vaccine is specifically recommended for individuals in need of robust protection against Meningococcal C infections. ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing these bacterial infections. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Meningococcal C vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the potential consequences of Meningococcal C infections. Your local pharmacy is ready to guide and support you throughout the Meningococcal C vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Thank you for booking your COVID-19 vaccination booster with our pharmacy. Please note that this vaccination is provided FREE of charge and as such, no payment is required. Please read on below for the general information on the vaccination.

Introduction to the Moderna XBB1.5 COVID-19 Vaccine:

The Moderna XBB1.5 COVID-19 vaccine, authorised by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is now available at pharmacies. Representing a significant advancement, this vaccine serves as a booster, augmenting immunity against COVID-19 and reinforcing our ongoing efforts to combat the challenges posed by the virus.

Utilizing cutting-edge mRNA vaccination technology, the Moderna XBB1.5 is recommended for individuals seeking a robust booster experience with additional protection against the current strains of COVID-19. Current guidelines prioritize the Moderna XBB1.5 for the majority of the population, ensuring comprehensive protection by incorporating the latest strains.

Who Should Consider the Moderna XBB1.5 Booster:

The Moderna XBB1.5 vaccine is specifically recommended for individuals looking to enhance their immunity with a booster shot. ATAGI endorses its use for this purpose, with clinical trials demonstrating its effectiveness in preventing COVID-19, including severe cases. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website --> here <-- and --> here <-- for the most up-to-date information.

Prioritising Your Health and Community Well-being:

By choosing the Moderna XBB1.5 COVID-19 vaccine, you proactively safeguard your health and contribute to community well-being. Your commitment to staying protected is highly valued, and your local pharmacy is ready to guide and support you throughout the Moderna XBB1.5 vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Polio Vaccination:

The Polio vaccination, sanctioned by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a fundamental defense against Polio, this vaccine is a pivotal component of preventive healthcare, contributing to the protection of individuals and communities.

Formulated with proven technology, the Polio vaccine is recommended for individuals seeking comprehensive protection against this viral infection. Current guidelines underscore the significance of the Polio vaccination, aligning with the latest public health recommendations.

Who Should Consider the Polio Vaccination:

The Polio vaccine is specifically recommended for individuals in need of robust protection against Polio. ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing Polio infections. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Polio vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the potential consequences of Polio infections. Your local pharmacy is ready to guide and support you throughout the Polio vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Shingles Vaccination:

The Shingles vaccination, authorised by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a crucial defense against Shingles (herpes zoster), this vaccine is a pivotal component of preventive healthcare, contributing to the protection of individuals and communities.

Formulated with proven technology, the Shingles vaccine is recommended for individuals seeking comprehensive protection against this viral infection. Current guidelines underscore the significance of the Shingles vaccination, aligning with the latest public health recommendations.

Who Should Consider the Shingles Vaccination:

The Shingles vaccine is specifically recommended for individuals in need of robust protection against Shingles (herpes zoster). ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing Shingles infections. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Shingles vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the potential consequences of Shingles infections. Your local pharmacy is ready to guide and support you throughout the Shingles vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Typhoid Vaccination:

The Typhoid vaccination, authorised by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a crucial defense against Typhoid, this vaccine is a pivotal component of preventive healthcare, contributing to the protection of individuals and communities.

Formulated with proven technology, the Typhoid vaccine is recommended for individuals seeking comprehensive protection against this bacterial infection. Current guidelines underscore the significance of the Typhoid vaccination, aligning with the latest public health recommendations.

Who Should Consider the Typhoid Vaccination:

The Typhoid vaccine is specifically recommended for individuals in need of robust protection against Typhoid. ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing Typhoid infections. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the Typhoid vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the potential consequences of Typhoid infections. Your local pharmacy is ready to guide and support you throughout the Typhoid vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Introduction to the Diphtheria, Tetanus, Pertussis (DTP) Vaccination:

The Diphtheria, Tetanus, Pertussis (DTP) vaccination, sanctioned by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Department of Health, is readily available at pharmacies. Serving as a crucial defense against Diphtheria, Tetanus, and Pertussis, this vaccine is a fundamental component of preventive healthcare, contributing to the protection of individuals and communities.

Formulated with proven technology, the DTP vaccine is recommended for individuals seeking comprehensive protection against these bacterial infections. Current guidelines emphasize the significance of the DTP vaccination, aligning with the latest public health recommendations.

Who Should Consider the DTP Vaccination:

The DTP vaccine is specifically recommended for individuals in need of robust protection against Diphtheria, Tetanus, and Pertussis. ATAGI endorses its use for this purpose, and the vaccine has demonstrated efficacy in preventing these bacterial infections. To ensure eligibility, it is essential to check the latest guidelines, which may evolve. Stay informed by visiting the official Australian Health Department website for the most up-to-date information.

Prioritising Health and Community Well-being:

By choosing the DTP vaccination, you are proactively contributing to your health and the well-being of the community. The commitment to immunization safeguards against the spread of Diphtheria, Tetanus, and Pertussis, potentially serious bacterial infections. Your local pharmacy is ready to guide and support you throughout the DTP vaccination process.

For more information or to learn more, please contact us directly, and our dedicated team will be happy to assist.

Personal Details

General Consents

Terms & Conditions

These terms apply to the administration to you of the Service from an authorised pharmacist. By consenting to receive the Service, you confirm that you have read and agreed to the following terms:
 

 I confirm and agree the following:          

  1. I am the minimum required age for receiving this service.
  2. I understand that the Service is subject to availability. 
  3. I will answer truthfully if the pharmacist asks for specific information about my health, past vaccinations or other conditions that may affect my participation.
  4. The Service provider and its employees, agents, sub-contractors, directors and related bodies corporate will not be responsible for any injury, loss or damage you suffer from the Service (except where liability cannot be excluded by law).          

Precautions and Contraindications - For Vaccination Services

I have read and understand information on precautions, contraindications and side effects (listed in each CMI and below), am aware of and accept any risks associated with the Vaccination and to my knowledge I do not suffer from any condition or circumstance that prevents me from having the Vaccination or makes it unsafe for me and agree to tell the Service provider prior to vaccination, if I:-

  • have had an allergic reaction to any previous vaccine
  • have recently had any other vaccine in the past 7 days (e.g. COVID-19 vaccine) 
  • are allergic to the active ingredients or any other ingredients in the vaccines
  • are suffering from an acute illness (e.g. an infection) or have a temperature higher than 38.5ºC  
  • have or have had an immune response or low immunity problem e.g. a disorder, corticosteroid, cyclosporin or cancer treatment (including radiation therapy)  
  • have or had allergies or allergic reactions e.g. itchy rash/hives, swelling of face, lips, mouth or tongue  
  • have a bleeding problem or bruise easily  
  • have ever fainted before, during or after having an injection  
  • have a known allergy to egg protein  
  • have a known allergy to latex, foods, preservatives or dyes  
  • intend to become pregnant, are pregnant or breast-feeding
  • have or have had Guillain-Barre Syndrome (an illness which affects the nervous system and can cause severe muscle weakness or paralysis) after getting a flu vaccine.

I understand that having one of these issues may not prevent me from having the vaccination, but having a discussion with the pharmacist beforehand will allow me to make an informed choice about vaccination.

I will immediately inform the pharmacist of any adverse changes I experience in the course of participating in the Vaccination or afterwards, including (but not limited to): discomfort, pain, dizziness, shortness of breath, wheezing, difficulty breathing, swelling of the face, lips, tongue or other parts of the body.

I understand that as part of receiving the Vaccination, the Service provider must securely submit a record of my Vaccination to the Australian Immunisation Register (AIR).

 

Side effects   

I understand that, like all medicines, these vaccines may have some mild side effects, such as pain, tenderness, redness, swelling, bruising and hardness at the injection site, flu-like symptoms such as headaches, muscles aches, sore throat, cough, fever and chills/shivering or other symptoms like nausea, vomiting or diarrhoea.

I understand that these symptoms do not mean I am sick, they are most likely to be my body’s natural response to the vaccine.  The vaccine is generally well tolerated however I should stay close by so that the pharmacist can keep an eye on me for 15 minutes after the vaccine.
                

Australian Immunisation Register (AIR) Reporting 
                
The Australian Government has introduced laws to ensure that every Australian can access their vaccination history through a safe and secure register. Vaccination providers must now report information in relation to vaccinations administered both within and outside Australia. To facilitate this reporting we may need to collect some additional personal information from you such as your Medicare details (if applicable) in order to submit a record of your Vaccination to the AIR.
                

 
Please answer all the questions ( scroll up you might have missed some questions ).

Eligibility Questionnaire